(Q35781256)

10 August 2017

1 reference

title

Muscle-derived stem cells for musculoskeletal tissue regeneration and repair (English)

1 reference

10 August 2017

Hairong Peng

1

1 reference

PubMed ID

15157924

10 August 2017

Johnny Huard

series ordinal

2

1 reference

10 August 2017

1 April 2004

1 reference

10 August 2017

Transplant Immunology

1 reference

10 August 2017

12

1 reference

10 August 2017

311-319

1 reference

10 August 2017

3-4

1 reference

Cells that participate in regeneration of skeletal muscle

10 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.009

Muscle satellite cells are multipotential stem cells that exhibit myogenic, osteogenic, and adipogenic differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.009

Myogenic specification of side population cells in skeletal muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.009

Muscle-derived hematopoietic stem cells are hematopoietic in origin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.009

Identification of a novel population of muscle stem cells in mice: potential for muscle regeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.009

Muscle stem cells differentiate into haematopoietic lineages but retain myogenic potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.009

Wnt signaling induces the myogenic specification of resident CD45+ adult stem cells during muscle regeneration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.009

The evolving concept of a stem cell: entity or function?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.009

Clonal isolation of muscle-derived cells capable of enhancing muscle regeneration and bone healing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.009

Intraarterial injection of muscle-derived CD34(+)Sca-1(+) stem cells restores dystrophin in mdx mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.009

The role of CD34 expression and cellular fusion in the regeneration capacity of myogenic progenitor cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.009

Identification of myogenic-endothelial progenitor cells in the interstitial spaces of skeletal muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.009

Skeletal myogenic progenitors originating from embryonic dorsal aorta coexpress endothelial and myogenic markers and contribute to postnatal muscle growth and regeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.009

Cell Therapy of -Sarcoglycan Null Dystrophic Mice Through Intra-Arterial Delivery of Mesoangioblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.009

Side population cells from diverse adult tissues are capable of in vitro hematopoietic differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.009

Vascular pericytes express osteogenic potential in vitro and in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.009

Osteoprogenitor cells of mature human skeletal muscle tissue: an in vitro study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.009

BMP4-expressing muscle-derived stem cells differentiate into osteogenic lineage and improve bone healing in immunocompetent mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.009

Altered phenotype and reduced function of muscle-derived hematopoietic stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.009

Stem cells in the treatment of muscle and connective tissue diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.009

Mechanisms of muscle stem cell expansion with cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.009

Wnt proteins are lipid-modified and can act as stem cell growth factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.009

A role for Wnt signalling in self-renewal of haematopoietic stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.009

Gene transfer into skeletal muscles by isogenic myoblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.009

High efficiency of muscle regeneration after human myoblast clone transplantation in SCID mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.009

Differentiation of muscle-derived cells into myofibroblasts in injured skeletal muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.009

Improvement of muscle healing through enhancement of muscle regeneration and prevention of fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.009

Gamma interferon as an antifibrosis agent in skeletal muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.009

The use of an antifibrosis agent to improve muscle recovery after laceration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.009

Invited review: myoblast transfer: a possible therapy for inherited myopathies?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.009

Matching host muscle and donor myoblasts for myosin heavy chain improves myoblast transfer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.009

Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.009

Satellite cell proliferative compartments in growing skeletal muscles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.009

Development of approaches to improve cell survival in myoblast transfer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.009

Identification of a putative pathway for the muscle homing of stem cells in a muscular dystrophy model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.009

Intramuscular Migration of Myoblasts Transplanted after Muscle Pretreatment with Metalloproteinases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.009

The urokinase plasminogen activator: an interesting way to improve myoblast migration following their transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.009

Muscle regeneration by bone marrow-derived myogenic progenitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.009

Dystrophin expression in the mdx mouse restored by stem cell transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.009

Biological progression from adult bone marrow to mononucleate muscle stem cell to multinucleate muscle fiber in response to injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.009

Generalized potential of adult neural stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.009

Skeletal myogenic potential of human and mouse neural stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.009

Skeletal muscle repair by adult human mesenchymal stem cells from synovial membrane.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.009

Changing potency by spontaneous fusion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.009

Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.009

Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.009

Growth factor regulation of fracture repair.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.009

Osteochondral progenitor cells in acute and chronic canine nonunions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.009

Bone: formation by autoinduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.009

Novel regulators of bone formation: molecular clones and activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.009

Purification and characterization of other distinct bone-inducing factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.009

Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.009

Antiangiogenic agent (TNP-470) inhibition of ectopic bone formation induced by bone morphogenetic protein-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.009

Development of an MFG-based retroviral vector system for secretion of high levels of functionally active human BMP4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.009

Enhancement of bone healing based on ex vivo gene therapy using human muscle-derived cells expressing bone morphogenetic protein 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.009

Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.009

Chondrocyte-fibrin matrix transplants for resurfacing extensive articular cartilage defects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.009

Effect of cultured autologous chondrocytes on repair of chondral defects in a canine model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.009

Healing of canine articular cartilage defects treated with microfracture, a type-II collagen matrix, or cultured autologous chondrocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.009

Treatment of osteochondritis dissecans of the knee with autologous chondrocyte transplantation: results at two to ten years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.009

Mosaicplasty for the treatment of articular cartilage defects: application in clinical practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.009

Regenerating hyaline cartilage in articular defects of old chickens using implants of embryonal chick chondrocytes embedded in a new natural delivery substance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.009

Chondrocyte-laden collagen scaffolds for resurfacing extensive articular cartilage defects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.009

The chondrogenic potential of human bone-marrow-derived mesenchymal progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.009

Effect of transforming growth factor beta1 on chondrogenic differentiation of cultured equine mesenchymal stem cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.009

Chondrocytic differentiation of mesenchymal stem cells sequentially exposed to transforming growth factor-beta1 in monolayer and insulin-like growth factor-I in a three-dimensional matrix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.009

Insulinlike growth factor-I gene therapy applications for cartilage repair.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.009

Direct adenovirus-mediated insulin-like growth factor I gene transfer enhances transplant chondrocyte function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.009

Repair of rabbit articular surfaces with allograft chondrocytes embedded in collagen gel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.009

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.TRIM.2003.12.009

1 reference

10 August 2017

1 reference

PubMed ID

15157924